INTRODUCTION
Gonadal dysgenesis in female is defined as absent or insufficient development of ovaries. 1 The patient with gonadal dysgenesis presents with primary amenorrhea and lack of development of secondary sexual characteristics due to inability of ovaries to produce sex steroids. The karyotype in patients with gonadal dysgenesis can be 46XX, 45XO, mosaicism or deletion of a certain part of X chromosome. 1 The Mayer-RokitanskyKuster-Hauser Syndrome (MRKHS) is a specific type of mullerian duct malformation characterized by congenital absence or hypoplasia of uterus and upper two thirds of the vagina in both phenotypically and karyotypically normal females with functional ovaries. 2 It is the second most common cause of primary amenorrhea. The disorder is rarely recognized in children because the external genitals are normal, no other abnormalities are visible & growth is normal. At pubertal age, sexual maturation fails to take place. Plasma gonadotropin levels are elevated. Pelvic ovaries revealed streak ovaries. If FSH and LH blood levels are low (hypogonadotropic hypogonadism), the most probable explanation is delayed puberty, frequently corresponding to family genetics. Less commonly, amenorrhoea could be due to infiltrative lesions of the hypothalamus or the pituitary gland.
CASE REPORT
Ropke et al. 8 consider mosaicism in gonadal karyotype as a frequent cause of gonadal dysgenesis, regardless of a normal peripheral karyotype. They strongly recommend testing the karyotype of the gonadal tissue because this information could be extremely useful. In addition, Massin et al. 9 recommend an ovarian biopsy in cases of pure gonadal dysgenesis due to the fact that it is a stronger indicator than pelvic ultrasound for the presence of follicles in the ovaries. These authors think that, in the near future, the ovarian biopsy could help in determining the aetiology and could even provide a therapeutic effect due to the success of in vitro growth of immature oocytes in humans.
MRKH syndrome is characterized by Mullerian duct structures agenesis, vaginal atresia, rudimentary or absent uterus with normal ovaries and Fallopian tubes in females normal from a genetic (46 XX), phenotypic and developmental features. The prevalence has been reported as 1 in 4.500 female births. 10 The etiology of MRKH syndrome is unknown but it is believed that embryological development is interrupted during the sixth or seventh week of gestation. Since the mesonephros (which give rise to kidneys), the Mullerian ducts, and the skeleton all originate from the mesoderm, it is believed that a deleterious event occurs during this phase of gestation, giving rise to the abnormalities seen in the MRKH syndrome.
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Estrogens may influence development of the Mullerian ducts. Absence of anti-Mullerian hormone is also essential for its development. The existence of activating mutations of either the gene for the anti-Mullerian hormone or the gene for the anti-Mullerian hormone receptor, and the lack of estrogen receptors during embryonic development have been hypothesized to cause MRKH syndrome. 12 The association of gonadal dysgenesis with Mullerian tract anomalies is extremely rare. It was first described by McDonough et al. in a girl with gonadal dysgenesis, duplication of the Mullerian duct system, and a 46, XX karyotype.
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CONCLUSION
The association of gonadal dysgenesis and MRKH syndrome is extremely rare. Long-term lack of oestrogens could cause early bone loss and osteoporosis in these patients. In addition, the lack of female sexual hormones represents an important risk factor for neurological, metabolic and cardiovascular health problems. Therefore, these patients would require replacement hormonal treatment with oestrogens and progesterone. This last hormone is required for reducing the risk of endometrial carcinoma, which will increase due to the long-term application of oestrogens without opposition. Sterility is an obvious consequence in patients with premature ovarian failure. Nevertheless, patients could become mothers with proper endometrial stimulation and subsequent implanting of embryos fertilised with donated ovules. An early diagnosis is extremely important in order to promptly begin treatment for the management of symptoms, provide emotional support to the patient and reduce the risks associated with this illness.
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